Intelligent Investor

Sonic Healthcare Limited (ASX: SHL) - Share Price and Research

Current share price for SHL : $26.470 0.26 (0.97%)

Sonic Healthcare (SHL), an ASX-listed company, is an international healthcare provider with specialist operations in pathology/laboratory medicine, radiology, general practice medicine and corporate medical services headquartered in Sydney, Australia

SHL General Information +

ASX Code SHL
Website http://www.sonichealthcare.com
Industry/Sector Health Care Services
Market Cap ($M) 12,716
SHL Share Price $26.470
Day High $26.550
Day Low $26.115
Last Close $26.730
SHL Share Price Movement $0.26 ( 0.97% )
Prices as at 16:40, 16 Apr 2024
+Security prices are delayed by at least 20 minutes and are indicative only.

Recommendation

Sonic Healthcare Limited - SHL
BUY
below Recommendation Locked
HOLD
up to Recommendation Locked
SELL
above Recommendation Locked
Current price
$26.47 at 16:40 (16 April 2024)

Price at review
$27.49 at (21 March 2024)

Max Portfolio Weighting
Maximum Portfolio Weighting Locked

Business Risk
Business Risk Locked

Share Price Risk
Share Price Risk Locked
All Prices are in AUD ($)
Upsell Banner

SHL Related Research

Sonic Healthcare Limited (SHL) Upcoming Dividends & Yields

Distribution Type Dividend Franking Ex-dividend date Payment date Current Price+ Price 7D Avg Dividend Yield
Result 43¢ 0% 1 Mar 2024 21 Mar 2024 $26.470 $28.770 3.93%
HFResult 62¢ 100% 6 Sep 2023 21 Sep 2023 $26.470 $28.770 3.93%
Result 42¢ 100% 7 Mar 2023 22 Mar 2023 $26.470 $28.770 3.93%

See all dividends from Sonic Healthcare Limited (SHL) or use our Upcoming Dividends tool to search for dividends across all ASX-listed securities.

Sonic Healthcare Limited (SHL) Recent ASX Announcements

Headline Annoucement date/time+ Price at announcement+ Current price+ Price 7D Avg Gain/Loss
Application for quotation of securities - SHL 9 Apr 2024 4:06PM $28.790 $26.470 $28.770 fallen by 8.06%
Application for quotation of securities - SHL 4 Apr 2024 4:07PM $29.000 $26.470 $28.770 fallen by 8.72%
Application for quotation of securities - SHL 25 Mar 2024 11:28AM $28.850 $26.470 $28.770 fallen by 8.25%
  • + Company announcements and prices are delayed by at least 20 minutes. Prices are indicative only.

See all ASX announcements from Sonic Healthcare Limited (SHL) or use our ASX Announcements tool to search for announcements across all ASX-listed securities.

SHL Financial Summary

Year to Jun NPAT EPS EPS chg (%) PER DPS Yield (%) Franking (%)
2025F $688.90 $138.26 21.60% 19.15 104.00 3.93% 30.0%
2024F $566.58 $113.71 -21.60% 23.28 85.00 3.21% 30.0%
2023A $684.98 $144.99 -53.00% 22.81 104.00 3.14% 100.0%

SHL Peer Comparison

Company Mkt Cap EPS Growth (%) P/E (%) Dividend Yield (%)
2023 A 2024 F 2025 F 2023 A 2024 F 2025 F 2023 A 2024 F 2025 F
Australian Clinical Labs (ACL) $494M -0.8335 -0.0326 0.2722 15.9713 16.5094 12.9767 5.71% 3.27% 4.69%
Healius (HLS) $879M -0.8248 -0.9826 37.4000 14.0209 806.6667 21.0069 0.00% 0.00% 3.31%
Integral Diagnostics (IDX) $554M -0.2212 0.2914 0.4914 35.0592 27.1478 18.2028 2.53% 2.65% 3.90%
Sonic Healthcare (SHL) $12,841M -0.5207 -0.2079 0.3159 18.4345 23.2738 17.6868 3.89% 3.57% 4.00%

SHL Market Comparison

Earnings P/E Ratio P/B Ratio P/E Growth
Company 0.69 21.90 1.61 10.46
Market 0.64 16.40 1.38 1.28
Sector 0.86 32.50 2.34 2.40

SHL Directors

Name Position Start Date
Dr Colin Stephen Goldschmidt Chief Executive Officer, Managing Director 28 Jan 1993
Mr Christopher David Wilks Chief Financial Officer, Finance Director 5 Dec 1989
Mr Neville Mitchell Non-Executive Director 29 Sep 2017
Mr Louis (Lou) James Panaccio Non-Executive Director 30 Jun 2005
Professor Suzanne Crowe Non-Executive Director 6 Apr 2020
Professor Christine Constance Bennett Non-Executive Director 26 Sep 2022
Ms Kathryn (Kate) Dianne Spargo Non-Executive Director 1 Jul 2010
Dr Katharine Giles Non-Executive Director 26 Sep 2022
Mr Mark Raymond Compton Non-Executive Director, Non-Executive Chairman 7 Oct 2014

Sonic Healthcare Limited (SHL) Changes in Directors' Interest & Trades

Date of change Director Buy/Sell Security Type Qty Trade Price Value
5 Mar 2024 BENNETT, Christine Buy Indirect Shares 1,100 $28.521 $31,373.430
1 Dec 2023 BENNETT, Christine Buy Indirect Shares 1,000 $29.000 $29,000.000
27 Nov 2023 COMPTON, Mark Buy Indirect Shares 1,000 $28.870 $28,869.900

See all changes in directors' interest & trades for Sonic Healthcare Limited (SHL) or use our Changes in directors' interest tool to search for changes & trades across all ASX-listed securities.

SHL Management

Name Position
Paul Joseph Alexander Company Secretary,Deputy Chief Financial Officer

SHL Substantial Shareholders

Under ASX rules large investors and investment funds must disclose when they own more than a 5% stake in Sonic Healthcare Limited (SHL). However, you won't necessarily see their names in the company’s annual report, as many trade under nominee names. These shareholders are obliged to provide ongoing substantial notices relating to any change of 1% or more.

Holding Name
29,790,944 (6.28%) State Street Corporation and subsidiaries
29,440,945 (6.21%) BlackRock Group
24,058,158 (5.07%) The Vanguard Group,Inc

SHL Calendar of Events

Date Event
18 February 2025 Report (Interim)
24 September 2024 Report (Annual)
15 August 2024 Report (Prelim)

FAQs about Sonic Healthcare Limited (SHL)

Sonic Healthcare Limited's (SHL) current share price is $26.47. This constitutes a price movement of 7.99% when compared to the share price 7 days ago and is -27.22% below SHL's 12-month high of $36.37 per share. Prices are delayed by at least 20 minutes.

Relative to the previous close share price of $26.73, Sonic Healthcare Limited's (SHL) current share price of $26.47 constitutes a movement of -$0.26 or -0.97%. Sonic Healthcare Limited's (SHL) share price movement is -7.99% when compared to 7 days ago and is -27.22% below SHL's 52-week high of $36.37.

Sonic Healthcare Limited's (SHL) 52-week high is $36.37 which was reached on 24 Apr 2023. Relative to this, SHL's current share price of $26.47 constitutes a -$9.90 or -27.22% drop since that high of $36.37 per SHL share.

Sonic Healthcare Limited's (SHL) 52-week low is $26.47 which was reached on 16 Apr 2024. Relative to this, SHL's current share price of $26.47 constitutes a or 0% drop since that low of $26.47 per SHL share.

Over the last 12 months, Sonic Healthcare Limited (SHL) has a daily average trading volume of 1,159,182 SHL shares per day.

Sonic Healthcare Limited (SHL) has a current dividend yield of n/a this year. Last year's dividend yield was 2.90%. The dividend yield for SHL is a ratio that tells you the percentage of Sonic Healthcare Limited's (SHL) share price that it pays out in dividends each year.

Sonic Healthcare Limited (SHL) last dividend payment was $0.43 per share and was paid on 21 Mar 2024. This last SHL dividend included 0% franking.

Sonic Healthcare Limited (SHL) has a franking level of 30%. Franking represents the tax Sonic Healthcare Limited (SHL) has already paid on any profit it distributes to shareholders as a dividend.

Sonic Healthcare Limited (SHL) will release its next Annual Report on 24 September 2024. Sonic Healthcare Limited's (SHL) last annual report was released on 26 Sep 2023. Click here to view Sonic Healthcare Limited's (SHL) last annual report.

Sonic Healthcare Limited (SHL) is classified as Health Care. Other companies in this sector include CSL Limited (CSL), Cochlear Limited (COH), ResMed Inc. (RMD), and Fisher & Paykel Healthcare Corporation Limited (FPH).

The price-to-earnings (P/E) ratio for Sonic Healthcare Limited (SHL) is 21.9. The price-to-earnings ratio, also known as P/E ratio, P/E, or PER, is the ratio of Sonic Healthcare Limited's (SHL) share price to its earnings per SHL share.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© 2017 Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.